Pharmarise Holdings Corp. (JP:2796) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmarise Holdings Corp. reports a 13.1% increase in net sales but a significant decline in profitability in the first three months of fiscal 2025, with operating and ordinary profits plunging by 84.1% and 93.0% respectively. The company’s overall financial position shows a slight decrease in total assets and net assets compared to the end of the previous fiscal year. Furthermore, Pharmarise projects modest growth in net sales but a sharp decrease in profit for the first half of the fiscal year, followed by a conservative full-year forecast.
For further insights into JP:2796 stock, check out TipRanks’ Stock Analysis page.

